Clinical Trial Update: Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating neoadjuvant nivolumab, with or without ipilimumab, in patients with advanced cut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED